900 - 200 Granville Street
Vancouver, BC
Canada V6C 1S4
T: 604.742.6200
Toll-free: 1.866.880.7101
bccnm.ca
(CDS) Prescribing
Nurse Practitioner
Controlled Drugs
and Substances
BCCNM LEARNING MODULE - WORKBOOK
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 2
Introduction
This workbook oers activities that allow you to apply ideas presented in the
Module. It is organized in three sections.
Part 1 includes Workbook Activities that are related to various topic areas. As you work through the module,
you will be directed to complete a specific Workbook Activity. This section also includes pages for you to record
your reflective thoughts and insights related to your exploration. This information will be useful for you in
completing your Professional Growth Plan at the completion of this module.
Part 2, Applying My Learning” includes a case scenario and associated questions. Completing these activities
provides an opportunity for you to apply the information that has been oered in the module in the context of
this practice based scenario. When you have completed this case, you may wish to compare your responses with
those provided in the “Applying my Learning: Perspectives” located in part 3.
Part 3, presents samples responses to Workbook case scenario in Part 2. These responses provide perspectives
of the course writer and others on the case scenario.
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 3
PART 1
Workbook activities
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 4
Workbook Activity #1
Consider the following questions. Record your responses in the spaces below. These thoughts, ideas, and
responses will help you form part of the basis for your professional development plan for CDs prescribing.
This is a good time to review the relevant legislation that you should be aware of in relation to your
responsibilities in CDS Prescribing. The BCCNM legislation relevant to nurses practice is a summary of the
Controlled Drugs and Sustances Act and Food and Drug Act. While reviewing the dierent legislations
below,write down specific items that are relevant to your practice.
BCCNM’s Legislation Relevant to Nurses Practice
https://www.bccnm.ca/Documents/regulation/LegislationRelevantNursesPractice.pdf
Controlled Drug and Substances Act (CDSA)
http://laws-lois.justice.gc.ca/eng/acts/C-38.8/
Part G Food and Drug Act Regulation link
https://laws-lois.justice.gc.ca/eng/acts/F-27/index.html
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 5
Workbook Activity #2
Please review the BC drug schedules regulation below, while reading through keep the posed questions in mind
and write down your answers in the space provided.
Review the BC Drug Schedule regulation of the Pharmacy Operations and Drug Scheduling Act
http://www.bclaws.ca/civix/document/id/complete/statreg/03077_01
1. What Drug Schedule(s) include(s) controlled drugs and substances?
2. What schedule of drugs falls under the Controlled Prescription program and requires a prescription is
written on a duplicate prescription form?
3. Identify some commonly prescribed control drugs in the BC drug schedule regulation that can be written
on a regular, personalized prescription form, and not a CPP duplicate prescription form.
4. If you are not sure if a drug is considered a controlled drug under the Controlled Drugs and Substances
Act, or if it needs a CPP duplicate prescription form, what resources are available to you to get answers
with this?
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 6
Workbook Activity #3
Read the revised Scope of Practice for NPs: https://www.bccnm.ca/NP/ScopePractice/Pages/Default.aspx
While you are reviewing this document focus on the questions below and jot down your thoughts in the
space provided.
1. Why is medication reconciliation and access to PharmaNet important to safe CDS prescribing? (BCCNM
NP Prescribing Standard 6 and 7)
2. What are some additional requirements in the NP prescribing standards related to prescribing CDS?
3. What must you consider and document before initiating or continuing the prescribing of CDS? (Refer to
NP prescribing Standards)
4. When prescribing CDS, NPs must assess the client in person. Are there any exceptions to this standard?
5. What are your responsibilities related to the security of all your prescription pads? (refer to NP
Prescribing Standards Limits and Conditions)
6. You have been approached by a family member. They say they are going on a long vacation and would
like to have some Tylenol #3 if needed. They have asked you to prescribe a few. How would you respond
and what prescribing standards and limits are most relevant?
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 7
Workbook Activity #4
Michael’s story is told by his mother Ada after his death. Read Michael’s Story in the report First Do No Harm
http://www.ccsa.ca/Resource%20Library/Canada-Strategy-Prescription-Drug-Misuse-Report-en.pdf on p.
4. Prior to reading this story you may want to refer the “Your Prescription: Your Responsibility”
https://www.cpsbc.ca/for-physicians/college-connector/2014-V02-03/06, as it provides guidance for
practicing pharmacovigilance.
While reading this story, please consider what contributed to this tragedy and what could have been done to
prevent tragedies like this. Write down your ideas in the space provided below.
CONTRIBUTING VARIABLES STRATEGIES FOR PREVENTION
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 8
Workbook Activity# 5
e World Health Organization (WHO) denes pharmacovigilance as:
“Pharmacovigilance ” (PV) is the science and activities relating to the detection, assessment, understanding and
prevention of adverse eects or any other drug related problem. Its aims are to enhance patient care and patient
safety and to support public health programmes by providing reliable, balanced information for the eective
assessment of the benefit-risk profile of medicines and vaccines.
World Health Organization Web Site
https://www.who.int/medicines/areas/quality_safety/safety_ecacy/pharmvigi/en/
BCCNM Scope of Practice for Nurse Practitioners
https://www.bccnm.ca/NP/ScopePractice/Pages/Default.aspx
1. Take a moment and review the WHO web site and the BCCNM Scope of Practice for Nurse Practitioners
to reflect on the key elements associated with pharmacovigilance. Now consider your practice settings
and client populations. What are the challenges you have encountered of foresee related to CDS
prescribing?
2. Reflect on the causes of the vulnerabilities and the safeguards that can be employed to improve safety
and prevent harm.
3. What are some potential strategies or resources available to you to ensure appropriate
pharmacovigilance and mitigate those risks?
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 9
Workbook Activity #6
Go through the workbook that you have completed. Notice areas where you have further questions, specific
interest, or need further development. Notice areas where you have strengths in relation to CDS Prescribing.
Pick at least three areas you would like to develop further and create a learning plan for you to meet your
own learning needs. You may find the following framework helpful for you to structure your learning plan. A
Professional Development Portfolio that can be completed electrically is also available on the BCCNM QA web
page. A link to a pdf of this document is below and make sure you save it to your computer to complete it.
BCCNM Quality Assurance Web Page
https://www.bccnm.ca/NP/QA/Pages/Default.aspx
PD Planning
https://www.bccnm.ca/NP/QA/annual/pd_plan/Pages/Default.aspx
My Plan for Growth
Goals
1.
2.
3.
Action Plan
People or places that I can investigate for learning strategies to help me meet my goals for growth are:
1.
2.
3.
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 10
My Plan for Growth
STRATEGY RESOURCES I NEED
TO IMPLEMENT THIS
STRATEGY
TARGET COMPLETION
DATE
OTHER THOUGHTS
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 11
My Thoughts and Notes From
Reflection Points
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 12
Armations and Insights
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 13
PART 2
Applying My Learning
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 14
Appl
ying My Learning
Activity
Work through the following case study and questions about Anna, a nurse practitioner working in primary care
clinic. When you’re finished, you may wish to compare your responses with those provided in the “Perspectives”
section at the end of this Workbook.
Case Scenario Part 1
Anna works in a busy primary care clinic, along with another NP and two GPs. She provides care for her own
group of clients, covers for colleagues and sees walk-in clients as well. Anna has practised as an NP for 6 months
and recently obtained prescribing authority for controlled drugs and substances.
Anna’s not familiar with Gerald, her last client of the day, and takes a few minutes to review his chart before
seeing him. She notes he has a history of anxiety, hypertension and chronic back pain due to a car accident three
years ago. She determines that, after an initial, unsuccessful trial of extended release morphine, his pain has
been managed with Fentanyl 50mcg/hr transdermal patch every 72 hours. He’s been on this medication for the
last two and a half years.
Entering the exam room, Anna introduces herself and listens to Gerald explain the reason for his visit. He
reports that he is bothered by increasing anxiety and difficulty focusing. He believes these issues are side
effects of his pain medication. He reports that although his pain is mostly under control, rating it 1-2 on a scale
of 10, he expresses that his daily activities are increasingly affected and he needs to do something..
After asking Gerald a few more questions about his medical history, Anna conducts a full assessment, focusing
on pain and management of pain medication symptoms.
Anna gathers some assessment tools including the Canadian Guideline for Safe and Effective Use of Opioids for
Chronic Non-Cancer Pain, Opioid Manager, GAD7, PHQ9 (see the links below).
As she conducts her assessment, she explains each tool’s purpose. As she documents her assessment, she
describes how the data will inform decisions about managing Gerald’s care.
Following the assessment, Gerald asks Anna several questions about his pain management plan and the side
effects he is experiencing. Anna is able to answer most but not all of Gerald questions. She explains that she’d
like to consult with a GP colleague in order to come up with a plan that would meet Gerald’s pain and symptom
management needs. Gerald agrees. While Anna waits for her colleague to arrive, she signs into PharmaNet to
gather a CDS prescriber history for Gerald.
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 15
1. Which Controlled Drugs and Substance Standards, Limits and Conditions provide direction and support
for Anna in this situation? Briefly explain how.
2. Consider the situation from the perspective of a nurse practitioner working in an NP only clinic. What
resources would be available to support Anna’s practice?
Tools:
Canadian guideline for Safe and Eective Use of Opioids for Chronic Non-Cancer Pain
http://nationalpaincentre.mcmaster.ca/documents/opioid_guideline_part_a_v4_5.pdf
Opioid manager
http://nationalpaincentre.mcmaster.ca/opioidmanager/opioid_manager_download.
html?appSession=430378086733936)
Generalized anxiety Disorder 7-item (GAD-7) scale
http://www.integration.samhsa.gov/clinical-practice/GAD708.19.08Cartwright.pdf
Patient Health Questionnaire (PHQ-9)
http://www.integration.samhsa.gov/images/res/PHQ%20-%20Questions.pdf
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 16
Case Scenario Part 2
Gerald is focused on his increasing anxiety and very determined to get a medication. During the discussion of
possible options to manage his anxiety, Anna brings up other options, such as an anxiety management support
group. Gerald doesn’t seem interested in participating in a support group, stating he has tried them before. He
also wonders that as his anxiety is most likely related to fentanyl use, “how would medicating and talking about
it be in any way helpful to him.”
Gerald suggests to Anna that she prescribe Xanax or something similar for his anxiety. He states that these
medications have been very helpful in decreasing his anxiety levels in the past.
1. Which Controlled Drugs and Substance Standards, Limits and Conditions provide direction and support
for Anna in this situation? Briefly explain how.
2. If you were Anna, how would you respond to Gerald’s request?
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 17
PART 3
Workbook Case
Perspectives
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 18
Workbook Case Perspectives
This section presents samples responses to Workbook case scenario in Part 2. These responses provide
perspectives of the course writer and others on the case scenario.
Case Scenario Part 1
Question #1
There are a number of contextual factors that are influencing Anna’s decision in this case. Here are some to
consider when you answer this question. You may have other ideas as well.
NP Prescribing Standard 1 – Nurse practitioners prescribe drugs within nurse practitioners’ scope of practice,
relevant legislation and individual competence.
NP Prescribing Standard 2- Nurse practitioners are solely accountable for their prescribing decisions including
when responding to requests for continuation of prescriptions ordered by another prescriber. Anna consults
with one of her colleagues to ensure continuity and best outcomes for her “new” client. Anna is aware that
Nurse practitioners prescribing controlled drugs and substances for the management of chronic pain requires
additional education in prescribing for this context of pain.
NP Prescribing Standard 6 – Considers the client’s health history (Anna conducts a thorough assessment prior
to making a decision about CDS prescribing). Anna accesses PharmaNet data to review the client’s medication
profile.
Question #2
Rapid Access for Consultative Expertise (RACE) Program and Line
The Canadian Guideline for Safe and Eective Use of Opioids for Chronic Non Cancer Pain
https://healthsci.mcmaster.ca/npc
BCCSU Clinical Guideleines
https://www.bccsu.ca/clinical-care-guidance/
The Center for Addiction and Mental Health provides several resources that may help you get more familiar with
mental health and addictions. See more at http://www.camh.ca/en/hospital/Pages/Home.aspx
As recommended in the module it is important for NPs who are introducing the prescribing of CDS into their
practice to initiate and maintain an on-going mentoring relationship with other practitioner(s) experienced in
prescribing CDS.
The College of Pharmacists of BC has developed a number of resources that are useful in understanding the
legislation and requirements when prescribing CDS. These resources should be used in conjunction with BCNM
resources and can be accessed on the CPBC website http://www.bcpharmacists.org/
BCCNM LEARNING MODULE / NURSE PRACTITIONER CONTROLLED DRUGS AND SUBSTANCES / 19
Question #3
You may find it helpful to identify resource gaps and strengths in your practice setting as this may help you
create your professional development plan.
Case Scenario Part 2
Question #1
Same as above (Part 1)
NP Prescribing Standards 4 & 5 — Nurse practitioners use current evidence to support decision-making when
prescribing. Nurse practitioners apply relevant guidelines when prescribing.
Question #2
You have probably considered the following:
This is a complex case with many variables. Consider best practice guidelines and include the client in the
development of his care plan.
Nurse practitioners engage in evidence-informed prescribing and consider best practice guidelines and other
relevant resources when prescribing for clients, including complementary or alternative health therapies.
Collaborate with other practitioner(s) experienced in prescribing CDS and refer to other resources such
as The Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non Cancer Pain.
http://nationalpaincentre.mcmaster.ca
Consider contraindications and potential drug interactions in particular with the ongoing use of psychotropic,
sedating, or narcotic medication. Avoid co-prescribing whenever possible.
Use additional tools to have a full perspective of the client’s status: see examples below.
Canadian guideline for Safe and Eective Use of Opioids for Chronic Non-Cancer Pain
http://nationalpaincentre.mcmaster.ca/documents/opioid_guideline_part_a_v4_5.pdf
Opioid manager
http://nationalpaincentre.mcmaster.ca/opioidmanager/opioid_manager_download.
html?appSession=430378086733936)
Generalized anxiety Disorder 7-item (GAD-7) scale
http://www.integration.samhsa.gov/clinical-practice/GAD708.19.08Cartwright.pdf
Patient Health Questionnaire (PHQ-9):
http://www.integration.samhsa.gov/images/res/PHQ%20-%20Questions.pdf
Additionally you may wish to consider online resources such as Pain BC. This site oers several resources for
health care providers as well as people living with chronic pain.
https://www.painbc.ca/health-professionals